| 15 Aug 2024 | OTHER | NeuroVive Pharmaceutical AB | 28,875,000 | 0.16 SEK | |
| 15 Aug 2024 | OTHER | NeuroVive Pharmaceutical AB | 11 | 0.00 SEK | |
| 15 Aug 2024 | OTHER | NeuroVive Pharmaceutical AB | 65,625,000 | 0.16 SEK | |
| 15 Aug 2024 | OTHER | NeuroVive Pharmaceutical AB | 25 | 0.00 SEK | |
| 19 Apr 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 3,936,812 | 0.16 SEK | |
| 19 Apr 2024 | PURCHASE | NeuroVive Pharmaceutical AB | 8,679,506 | 0.16 SEK | |
| 17 Apr 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 20,161,209 | 0.16 SEK | |
| 17 Apr 2024 | GRANT_AWARD | NeuroVive Pharmaceutical AB | 44,483,379 | 0.16 SEK | |
| 10 Jun 2022 | OTHER | NeuroVive Pharmaceutical AB | 23,997,857 | 0.35 SEK | |
| 10 Jun 2022 | OTHER | NeuroVive Pharmaceutical AB | 81 | 0.00 SEK | |
| 10 Jun 2022 | OTHER | NeuroVive Pharmaceutical AB | 53,032,301 | 0.35 SEK | |
| 10 Jun 2022 | OTHER | NeuroVive Pharmaceutical AB | 179 | 0.00 SEK | |